XIAP and neoplasm: Mechanistically, the high expression of PD-1 in RT cells could activate pro-survival AKT/mTOR pathways and upregulates the expression of anti-apoptotic proteins (Bcl-2, Mcl-1, and XIAP), thus promoting tumor resilience, under targeted therapies [91].